{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:22:40Z","timestamp":1790054560026,"version":"4.0.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1038\/ajg.2016.162","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T08:02:03Z","timestamp":1463472123000},"page":"1014-1022","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten Challenge"],"prefix":"10.14309","volume":"111","author":[{"given":"Marlou P M","family":"Adriaanse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A","family":"Leffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran P","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M","family":"Najarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim A","family":"Buurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita C E","family":"Vreugdenhil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210210","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMra071600","article-title":"Celiac disease.","volume":"357","author":"Green","year":"2007","journal-title":"N Engl J Med"},{"key":"R2-27-20210210","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1038\/ajg.2010.276","article-title":"Update on serologic testing in celiac disease.","volume":"105","author":"Leffler","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R3-27-20210210","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1023\/A:1010729207320","article-title":"Celiac disease without villous atrophy: revision of criteria called for.","volume":"46","author":"Kaukinen","year":"2001","journal-title":"Dig Dis Sci"},{"key":"R4-27-20210210","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/gutjnl-2012-302196","article-title":"Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease.","volume":"62","author":"Leffler","year":"2012","journal-title":"Gut"},{"key":"R5-27-20210210","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajcn\/85.1.160","article-title":"A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease.","volume":"85","author":"Catassi","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"R6-27-20210210","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10620-011-1906-5","article-title":"Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials.","volume":"57","author":"Siegel","year":"2012","journal-title":"Dig Dis Sci"},{"key":"R7-27-20210210","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/apt.12147","article-title":"Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study.","volume":"37","author":"Kelly","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R8-27-20210210","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/ajg.2012.211","article-title":"A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge.","volume":"107","author":"Leffler","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R9-27-20210210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/B978-0-12-416039-2.00013-6","article-title":"Oral enzyme therapy for celiac sprue.","volume":"502","author":"Bethune","year":"2012","journal-title":"Methods Enzymol"},{"key":"R10-27-20210210","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1080\/00365520510023855","article-title":"Enzyme therapy for management of coeliac disease.","volume":"40","author":"Cornell","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"R11-27-20210210","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/gut.20.9.743","article-title":"Reintroduction of gluten in adults and children with treated coeliac disease.","volume":"20","author":"Kumar","year":"1979","journal-title":"Gut"},{"key":"R12-27-20210210","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/gut.2006.100511","article-title":"Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet.","volume":"56","author":"Matysiak-Budnik","year":"2007","journal-title":"Gut"},{"key":"R13-27-20210210","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MPG.0b013e31817d8120","article-title":"Changing phenotype of celiac disease after long-term gluten exposure.","volume":"47","author":"Kurppa","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R14-27-20210210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1471-230X-11-129","article-title":"Small-bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease.","volume":"11","author":"Lahdeaho","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"R15-27-20210210","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00418-009-0608-y","article-title":"Localization, function and regulation of the two intestinal fatty acid-binding protein types.","volume":"132","author":"Levy","year":"2009","journal-title":"Histochem Cell Biol"},{"key":"R16-27-20210210","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/MCG.0b013e31819194b0","article-title":"A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP.","volume":"43","author":"Derikx","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"R17-27-20210210","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3109\/00365521.2011.627447","article-title":"Additional value of serum I-FABP levels for evaluating celiac disease activity in children.","volume":"46","author":"Vreugdenhil","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"R18-27-20210210","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/apt.12194","article-title":"Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.","volume":"37","author":"Adriaanse","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R19-27-20210210","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cgh.2008.12.032","article-title":"A simple validated gluten-free diet adherence survey for adults with celiac disease.","volume":"7","author":"Leffler","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R20-27-20210210","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.cgh.2009.07.031","article-title":"A validated disease-specific symptom index for adults with celiac disease.","volume":"7","author":"Leffler","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R21-27-20210210","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1008841022998","article-title":"Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease.","volume":"7","author":"Revicki","year":"1998","journal-title":"Qual Life Res"},{"key":"R22-27-20210210","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1365-2036.2007.03501.x","article-title":"A prospective comparative study of five measures of gluten-free diet adherence in adults with coeliac disease.","volume":"26","author":"Leffler","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R23-27-20210210","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1572-0241.2000.01838.x","article-title":"Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery.","volume":"95","author":"Dickey","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R24-27-20210210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00005176-199507000-00012","article-title":"Endomysial antibodies as unreliable markers for slight dietary transgressions in adolescents with celiac disease.","volume":"21","author":"Troncone","year":"1995","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R25-27-20210210","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0016-5085(92)91819-P","article-title":"Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (celiac sprue).","volume":"102","author":"Marsh","year":"1992","journal-title":"Gastroenterology"},{"key":"R26-27-20210210","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1572-0241.2001.03812.x","article-title":"Gluten challenge in borderline gluten-sensitive enteropathy.","volume":"96","author":"Wahab","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R27-27-20210210","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0753-3322(01)80003-2","article-title":"Histopathology of celiac disease.","volume":"54","author":"Oberhuber","year":"2000","journal-title":"Biomed Pharmacother"},{"key":"R28-27-20210210","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00281-012-0316-x","article-title":"Intraepithelial lymphocytes in celiac disease immunopathology.","volume":"34","author":"Abadie","year":"2012","journal-title":"Semin Immunopathol"},{"key":"R29-27-20210210","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1136\/gut.34.11.1515","article-title":"Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study.","volume":"34","author":"Catassi","year":"1993","journal-title":"Gut"},{"key":"R30-27-20210210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0950-3528(95)90032-2","article-title":"Morphology of the mucosal lesion in gluten sensitivity.","volume":"9","author":"Marsh","year":"1995","journal-title":"Baillieres Clin Gastroenterol"},{"key":"R31-27-20210210","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/ajg.2010.153","article-title":"How patchy is patchy villous atrophy? Distribution pattern of histological lesions in the duodenum of children with celiac disease.","volume":"105","author":"Ravelli","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R32-27-20210210","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/gutjnl-2012-302196","article-title":"Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease.","volume":"62","author":"Leffler","year":"2013","journal-title":"Gut"},{"key":"R33-27-20210210","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/ajg.2010.10","article-title":"Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet.","volume":"105","author":"Rubio-Tapia","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R34-27-20210210","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1365-2036.2009.03992.x","article-title":"Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet.","volume":"29","author":"Lanzini","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R35-27-20210210","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1309\/EVXT-851X-WHLC-RLX9","article-title":"Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery.","volume":"118","author":"Wahab","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R36-27-20210210","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1067\/mge.2003.54","article-title":"Duodenal histology in patients with celiac disease after treatment with a gluten-free diet.","volume":"57","author":"Lee","year":"2003","journal-title":"Gastrointest Endosc"},{"key":"R37-27-20210210","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/gut.30.1.78","article-title":"Early biochemical responses of the small intestine of coeliac patients to wheat gluten.","volume":"30","author":"Bailey","year":"1989","journal-title":"Gut"},{"key":"R38-27-20210210","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/00365529509093269","article-title":"Confocal laser scanning microscopy of small-intestinal mucosa in celiac disease.","volume":"30","author":"Holmgren Peterson","year":"1995","journal-title":"Scand J Gastroenterol"},{"key":"R39-27-20210210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1515\/cclm.2011.714","article-title":"The old and new tests for celiac disease: which is the best test combination to diagnose celiac disease in pediatric patients?","volume":"50","author":"Brusca","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"R40-27-20210210","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.dld.2007.06.004","article-title":"IgA anti-actin antibodies ELISA in coeliac disease: a multicentre study.","volume":"39","author":"Carroccio","year":"2007","journal-title":"Dig Liver Dis"},{"key":"R41-27-20210210","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/j.1572-0241.2004.30296.x","article-title":"Enterocyte actin autoantibody detection: a new diagnostic tool in celiac disease diagnosis: results of a multicenter study.","volume":"99","author":"Clemente","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R42-27-20210210","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/gut.47.4.520","article-title":"Immune reaction against the cytoskeleton in coeliac disease.","volume":"47","author":"Clemente","year":"2000","journal-title":"Gut"},{"key":"R43-27-20210210","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/apt.12147","article-title":"Larazotide acetate in patient with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study.","volume":"37","author":"Kelly","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R44-27-20210210","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/ajg.2012.211","article-title":"A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge.","volume":"107","author":"Leffer","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R45-27-20210210","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2014.02.031","article-title":"Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.","volume":"146","author":"Lahdeaho","year":"2014","journal-title":"Gastroenterology"},{"key":"R46-27-20210210","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1136\/gut.2007.128934","article-title":"Urine based detection of intestinal mucosal cell damage in neonates with suspected necrotising enterocolitis.","volume":"56","author":"Derikx","year":"2007","journal-title":"Gut"},{"key":"R47-27-20210210","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/shk.0b013e3180644e32","article-title":"Evidence for intestinal and liver epithelial cell injury in the early phase of sepsis.","volume":"28","author":"Derikx","year":"2007","journal-title":"Shock"},{"key":"R48-27-20210210","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/gast.1996.v110.pm8566578","article-title":"Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans.","volume":"110","author":"Kanda","year":"1996","journal-title":"Gastroenterology"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2016162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2016162","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2016162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201607000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:12:42Z","timestamp":1786547562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201607000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2016.162","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}